← All trials
NCT02314559
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2015
- Primary completion
- Jul 7, 2020
- Completion date
- Jul 7, 2020
- First posted
- Dec 11, 2014
- Last posted
- Jul 19, 2022
- Enrollment
- 164
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Free University of BrusselsLead sponsor
- Free University of BrusselsReponsible party - principal investigator
- CHU BrugmannOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.